BioSig Technologies, Inc., following its merger with Streamex Exchange Corporation, has secured up to $1.1 billion in growth financing from a leading institutional investor. The transaction, led by Cantor Fitzgerald & Co., Clear Street LLC, and Needham & Company, LLC, aims to position BioSig as one of Nasdaq's largest public holders of gold bullion. This strategic move will support the launch of a gold-backed treasury management strategy and accelerate the company's efforts in real-world asset tokenization for the $142 trillion commodities market. With this financing, BioSig is set to transform global finance by integrating gold and commodities on-chain, enhancing liquidity, transparency, and accessibility.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。